beta-lactams has been researched along with telavancin in 3 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (telavancin) | Trials (telavancin) | Recent Studies (post-2010) (telavancin) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 245 | 29 | 139 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E | 1 |
| Cattoir, V; Daurel, C | 1 |
| Chapman, AL; Lessing, MP; Sanderson, F; Seaton, RA; Török, ME | 1 |
2 review(s) available for beta-lactams and telavancin
| Article | Year |
|---|---|
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Daptomycin; Dosage Forms; Ertapenem; Humans; Infusions, Parenteral; Lipoglycopeptides; Teicoplanin | 2010 |
1 other study(ies) available for beta-lactams and telavancin
| Article | Year |
|---|---|
Antimicrobial development in the era of emerging resistance.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration | 2009 |